-
Smith became Viatris' CEO,
succeeding Michael Goettler.
Smith previously served on the company's
board since 2022. In
April 2023,
Viatris was recognized...
-
Creation VIATRIS TSR
Execution Plan" (PDF).
Champion For
Global Health.
Retrieved October 22, 2020. Sabatini,
Patricia (November 12, 2019). "
Viatris picked...
-
Biocon signed a
collaboration agreement with
Viatris to
develop and
commercialize generic biologics.
Viatris and
Biocon will
share development, capital...
- acid In some countries,
Dymista is
marketed by
Viatris after Upjohn merged with
Mylan to
create Viatris. In 2022, the
combination azelastine/fluticasone...
- Zenpep. In some countries,
Creon is
marketed by
Viatris after Upjohn merged with
Mylan to
create Viatris.
Longstanding pancreatic enzyme replacement products...
- "
Viatris Reports Fourth Quarter and Full Year 2024
Financial Results". "
Viatris Reports Fourth-Quarter and Full-Year 2023
Financial Results". "
Viatris...
-
Retrieved 27
April 2022. "
Viatris Closes Acquisitions of
Oyster Point Pharma and Famy Life Sciences,
Establishing New
Viatris Eye Care Division" (Press...
- treatment,
there was no
increase in HF risk. In the US,
Cardura is
marketed by
Viatris after Upjohn was spun off from Pfizer. A 2021
study ****ociated doxazosin...
-
Covidien Univar –
Univar Ltd
Valeant –
Valeant Pharmaceuticals Ltd
Viatris –
Viatris Pharmaceuticals Ltd W-L –
Warner Lambert UK Ltd (Pfizer Ltd) Warner...
-
hepatitis C. The
applicant for this
medicinal product is
Viatris Limited.
Eltrombopag Viatris was
authorized in
December 2024. It has been
shown to produce...
